GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC

PLoS One. 2012;7(8):e43255. doi: 10.1371/journal.pone.0043255. Epub 2012 Aug 14.

Abstract

Background: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components.

Methods and findings: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform.

Conclusions: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow / metabolism
  • Bone Marrow Cells / cytology*
  • Cell Culture Techniques / methods
  • Cell Differentiation
  • Chemokines / metabolism
  • Culture Media / pharmacology
  • Cytokines / metabolism
  • Flow Cytometry / methods
  • Glucose / metabolism
  • Humans
  • Integrins / metabolism
  • Karyotyping / methods
  • Lactic Acid / metabolism
  • Mesenchymal Stem Cells / cytology*
  • Polymerase Chain Reaction / methods
  • Stem Cells
  • Tissue Engineering / methods

Substances

  • Chemokines
  • Culture Media
  • Cytokines
  • Integrins
  • Lactic Acid
  • Glucose

Grants and funding

This work was supported by grants from the 7th Framework Program of the European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue) (number 223236; HEALTH-F5-2009-223236) and REBORNE (Regenerating BOne defects using New biomedical Engineering approaches) (number HEALTH- 2009-1.4.2-241879), and the University Centre of Musculoskelettal Research, Ulm, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.